Comparative study of the molecular mechanisms underlying the G protein and β‐arrestin‐dependent pathways that lead to ERKs activation upon stimulation by dopamine D 2 receptor
The FEBS Journal · 2023
DOI: 10.1111/febs.16921 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The FEBS Journal, 2023. Verfasst von Haiping Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guizhou University, Guiyang, China. Hauptthemen laut MEDLINE: Dopamine, Extracellular Signal-Regulated MAP Kinases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou University.
Abstract (Originalsprache)
Dopamine D 2 receptor (D 2 R) has been shown to activate extracellular signal‐regulated kinases (ERKs) via distinct pathways dependent on either G‐protein or β‐arrestin. However, there has not been a systematic study of the regulatory process of D 2 R‐mediated ERKs activation by G protein‐ versus β‐arrestin‐dependent signaling since D 2 R stimulation of ERKs reflects the simultaneous action of both pathways. Here, we investigated that differential regulation of D 2 R‐mediated ERKs activation via these two pathways. Our results showed that G protein‐dependent ERKs activation was transient, rapid, reached maximum level at around 2 min, and importantly, the activated ERKs were entirely confined to the cytoplasm. In contrast, β‐arrestin‐dependent ERKs activation was more sustained, slower, reached maximum level at around 10 min, and phosphorylated ERKs translocated into the nucleus. Src was found to be commonly involved in both the G protein‐ and β‐arrestin‐dependent pathway‐mediated ERKs activation. Pertussis toxin Gi/o inhibitor, GRK2‐CT, AG1478 epidermal growth factor receptor inhibitor, and wortmannin phosphoinositide 3‐kinase inhibitor all blocked G protein‐dependent ERKs activation. In contrast, GRK2 and β‐Arr2 played a main role in β‐arrestin‐dependent ERKs activation. Receptor endocytosis showed minimal effect on the activation of ERKs mediated by both pathways. Furthermore, we found that the formation of a complex composed of phospho‐ERKs, β‐Arr2, and importinβ1 promoted the nuclear translocation of activated ERKs. The differential regulation of various cellular components, as well as temporal and spatial patterns of ERKs activation via these two pathways, suggest the existence of distinct physiological outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.
- Mitchell Cancer Institute, School of Medicine, University of South Alabama, Mobile, AL, USA.
- Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, China.
- Department of Pharmaceuticals, People's Hospital of Zunyi City Bo Zhou District, China.
ORCID-Profile: Xiaohan Zhang
Förderung
- National Natural Science Foundation of China
- Guizhou University
Zitieren
APA
Liu, H., Acharya, S., Sudan, S. K., Hu, L., Wu, C., Cao, Y., Li, H., & Zhang, X. (2023). Comparative study of the molecular mechanisms underlying the G protein and β‐arrestin‐dependent pathways that lead to ERKs activation upon stimulation by dopamine D 2 receptor. The FEBS Journal. https://doi.org/10.1111/febs.16921
Vancouver
Liu H, Acharya S, Sudan SK, Hu L, Wu C, Cao Y, et al. Comparative study of the molecular mechanisms underlying the G protein and β‐arrestin‐dependent pathways that lead to ERKs activation upon stimulation by dopamine D 2 receptor. The FEBS Journal. 2023. doi:10.1111/febs.16921
BibTeX
@article{Liu2023,
author = {Liu, Haiping and Acharya, Srijan and Sudan, Sarabjeet Kour and Hu, Li and Wu, Chengyan and Cao, Yongkai and Li, Huijun and Zhang, Xiaohan},
title = {Comparative study of the molecular mechanisms underlying the G protein and β‐arrestin‐dependent pathways that lead to ERKs activation upon stimulation by dopamine D 2 receptor},
journal = {The FEBS Journal},
year = {2023},
doi = {10.1111/febs.16921}
}
EUVIMED